|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 145.50 GBX | -0.68% |
|
-0.34% | +13.67% |
| 02/06 | Diaceutics PLC, 2025 Earnings Call, May 26, 2026 | |
| 26/05 | Diaceutics PLC Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Life Sciences Tools and Services | ||||||||||
Medical Labs & Research | 1.39Cr | 1.95Cr | 2.37Cr | 3.22Cr | 3.84Cr | |||||
Total Assets | 4.5Cr | 4.83Cr | 4.63Cr | 4.86Cr | 5Cr | |||||
Interest Expense | -88T | -1L | -66T | -54T | -58T | |||||
Income Tax Expense | -99T | -2L | -7L | -2L | 2L | |||||
CAPEX | -56.01L | -48.7L | -1L | -1L | -71T | |||||
EBT | 5L | 6L | -24.38L | -19.08L | 3L | |||||
Gross Profit | 1.07Cr | 1.67Cr | 1.97Cr | 2.83Cr | 3.15Cr | |||||
D&A | 10.16L | 16.58L | 32.73L | 31.61L | 43.33L | |||||
Operating Income | 6L | 6L | -30.18L | -24.55L | 43T | |||||
Net Income | 6L | 7L | -17.46L | -17.03L | 97T |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
North America | 84.57L | 1.45Cr | 2.08Cr | 2.95Cr | 3.58Cr | |||||
Europe | 36.23L | 26.96L | 24.7L | 18.93L | 17.9L | |||||
UK | 6L | 6L | 4L | 5L | 8L | |||||
Asia and Rest of World | 13.08L | 17.93L | 45T | 2L | 33T | |||||
Asia | - | - | - | - | - | |||||
USA | - | - | - | - | - | |||||
Europe and USA | - | - | - | - | - |
- Stock Market
- Stocks
- DXRX Stock
- Financials Diaceutics PLC
- Business Segments
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
